$CDLX
Cardlytics, Inc. Stock $cdlx

$cdlx Overview Financials Valuation SEC Filings Company Website

2018 Q1 Form 10-Q Financial Statement

#000162828018006582 Filed on May 10, 2018

Income Statement

Concept	2018 Q1	2017 Q1
Revenue	$32.71M	$26.88M
YoY Change	21.7%	38.99%
Cost Of Revenue	$21.42M	$16.68M
YoY Change	28.42%	45.42%
Gross Profit	$11.29M	$10.20M
YoY Change	10.69%	29.44%
Gross Profit Margin	34.51%	37.95%
Selling, General & Admin	$14.80M	$11.92M
YoY Change	24.13%	-16.87%
% of Gross Profit	131.07%	116.87%
Research & Development	$3.459M	$3.013M
YoY Change	14.8%	-26.51%
% of Gross Profit	30.64%	29.54%
Depreciation & Amortization	$910.0K	$765.0K
YoY Change	18.95%	7.75%
% of Gross Profit	8.06%	7.5%
Operating Expenses	$18.26M	$14.93M
YoY Change	22.25%	-22.02%
Operating Profit	-$9.817M	-$7.048M
YoY Change	39.29%	-37.46%
Interest Expense	-$10.92M	-$5.580M
YoY Change	95.7%	1330.77%
% of Operating Profit
Other Income/Expense, Net	-$10.24M	-$5.415M
YoY Change	89.07%	1982.69%
Pretax Income	-$20.06M	-$12.46M
YoY Change	60.92%	4.56%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$20.06M	-$12.46M
YoY Change	60.92%	4.56%
Net Earnings / Revenue	-61.31%	-46.36%
Basic Earnings Per Share
Diluted Earnings Per Share	-$1.532M	-$638.3K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2018 Q1	2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$89.80M	$24.40M
YoY Change	268.03%
Cash & Equivalents	$89.79M	$24.35M
Short-Term Investments
Other Short-Term Assets	$3.700M	$2.000M
YoY Change	85.0%
Inventory
Prepaid Expenses
Receivables	$39.91M	$35.10M
Other Receivables	$2.748M	$2.000M
Total Short-Term Assets	$136.1M	$63.50M
YoY Change	114.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.363M	$8.000M
YoY Change	-7.96%
Goodwill
YoY Change
Intangibles	$359.0K
YoY Change
Long-Term Investments
YoY Change
Other Assets	$988.0K	$9.100M
YoY Change	-89.14%
Total Long-Term Assets	$21.71M	$17.60M
YoY Change	23.35%
TOTAL ASSETS
Total Short-Term Assets	$136.1M	$63.50M
Total Long-Term Assets	$21.71M	$17.60M
Total Assets	$157.8M	$81.10M
YoY Change	94.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.783M	$3.000M
YoY Change	-40.57%
Accrued Expenses	$3.918M	$5.400M
YoY Change	-27.44%
Deferred Revenue
YoY Change
Short-Term Debt	$25.60M	$0.00
YoY Change
Long-Term Debt Due	$25.66M	$100.0K
YoY Change	25557.0%
Total Short-Term Liabilities	$80.80M	$32.50M
YoY Change	148.62%
LONG-TERM LIABILITIES
Long-Term Debt	$32.89M	$126.8M
YoY Change	-74.06%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$36.45M	$126.8M
YoY Change	-71.26%
TOTAL LIABILITIES
Total Short-Term Liabilities	$80.80M	$32.50M
Total Long-Term Liabilities	$36.45M	$126.8M
Total Liabilities	$117.2M	$163.3M
YoY Change	-28.2%
SHAREHOLDERS EQUITY
Retained Earnings	-$288.5M
YoY Change
Common Stock	$328.5M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$40.56M	-$82.10M
YoY Change
Total Liabilities & Shareholders Equity	$157.8M	$81.10M
YoY Change	94.58%

Cashflow Statement

Concept	2018 Q1	2017 Q1
OPERATING ACTIVITIES
Net Income	-$20.06M	-$12.46M
YoY Change	60.92%	4.56%
Depreciation, Depletion And Amortization	$910.0K	$765.0K
YoY Change	18.95%	7.75%
Cash From Operating Activities	-$90.00K	-$5.824M
YoY Change	-98.45%	-52.65%
INVESTING ACTIVITIES
Capital Expenditures	$418.0K	$386.0K
YoY Change	8.29%	-134.16%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$794.0K	-$402.0K
YoY Change	97.51%	-64.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$70.49M	$270.0K
YoY Change	26007.41%	237.5%
Debt Paid & Issued, Net	$26.00K	$24.00K
YoY Change	8.33%
Cash From Financing Activities	$69.23M	$7.565M
YoY Change	815.16%	-225.66%
NET CHANGE
Cash From Operating Activities	-$90.00K	-$5.824M
Cash From Investing Activities	-$794.0K	-$402.0K
Cash From Financing Activities	$69.23M	$7.565M
Net Change In Cash	$68.52M	$1.385M
YoY Change	4847.51%	-107.12%
FREE CASH FLOW
Cash From Operating Activities	-$90.00K	-$5.824M
Capital Expenditures	$418.0K	$386.0K
Free Cash Flow	-$508.0K	-$6.210M
YoY Change	-91.82%	-44.4%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q1	cdlx	Adjusted Contribution AdjustedContribution	10595000	USD
CY2018Q1	cdlx	Adjusted Contribution AdjustedContribution	14224000	USD
CY2018Q1	cdlx	Adjustments To Additional Paid In Capital Accretion To Redemption Value AdjustmentsToAdditionalPaidInCapitalAccretionToRedemptionValue	157000	USD
CY2018Q1	cdlx	Adjustmentsto Additional Paidin Capital Preferred Stock Warrant Conversion Common Stock Warrant AdjustmentstoAdditionalPaidinCapitalPreferredStockWarrantConversionCommonStockWarrant	1736000	USD
CY2017Q1	cdlx	Capitalized Software Development Costs Incurredbut Notyet Paid CapitalizedSoftwareDevelopmentCostsIncurredbutNotyetPaid	0	USD
CY2018Q1	cdlx	Capitalized Software Development Costs Incurredbut Notyet Paid CapitalizedSoftwareDevelopmentCostsIncurredbutNotyetPaid	141000	USD
CY2017Q2	cdlx	Class Of Warrant Or Right Number Of Trading Days ClassOfWarrantOrRightNumberOfTradingDays	P30D
CY2017Q2	cdlx	Class Of Warrant Or Right Numerator Input Value ClassOfWarrantOrRightNumeratorInputValue	68.9516
CY2013Q2	cdlx	Class Of Warrant Or Right Term ClassOfWarrantOrRightTerm	P10Y
CY2016Q3	cdlx	Class Of Warrant Or Right Term ClassOfWarrantOrRightTerm	P10Y
CY2017Q2	cdlx	Class Of Warrant Or Right Term ClassOfWarrantOrRightTerm	P10Y
CY2017Q1	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	13200000	USD
CY2018Q1	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	16000000	USD
CY2017Q4	cdlx	Customer Incentive Liability CustomerIncentiveLiability	7242000	USD
CY2018Q1	cdlx	Customer Incentive Liability CustomerIncentiveLiability	6949000	USD
CY2017Q1	cdlx	Deferred Financial Institution Implementation Costs DeferredFinancialInstitutionImplementationCosts	0	USD
CY2018Q1	cdlx	Deferred Financial Institution Implementation Costs DeferredFinancialInstitutionImplementationCosts	250000	USD
CY2017Q1	cdlx	Deferred Implementation Costs Amortization DeferredImplementationCostsAmortization	391000	USD
CY2018Q1	cdlx	Deferred Implementation Costs Amortization DeferredImplementationCostsAmortization	412000	USD
CY2018Q1	cdlx	Deferred Implementation Costs Amortization Expense Current Fiscal Year DeferredImplementationCostsAmortizationExpenseCurrentFiscalYear	5400000	USD
CY2018Q1	cdlx	Deferred Implementation Costs Amortization Expense Year Two DeferredImplementationCostsAmortizationExpenseYearTwo	4600000	USD
CY2017Q1	cdlx	Deferred Offering Costs Incurred During Period DeferredOfferingCostsIncurredDuringPeriod	776000	USD
CY2018Q1	cdlx	Deferred Offering Costs Incurred During Period DeferredOfferingCostsIncurredDuringPeriod	1135000	USD
CY2018Q1	cdlx	Deferred Offering Costs Unpaid DeferredOfferingCostsUnpaid	700000	USD
CY2017Q1	cdlx	Delivery Costs DeliveryCosts	1553000	USD
CY2018Q1	cdlx	Delivery Costs DeliveryCosts	1943000	USD
CY2017Q1	cdlx	Fair Value Adjustment Of Convertible Promissory Notes FairValueAdjustmentOfConvertiblePromissoryNotes	-383000	USD
CY2018Q1	cdlx	Fair Value Adjustment Of Convertible Promissory Notes FairValueAdjustmentOfConvertiblePromissoryNotes	0	USD
CY2017Q1	cdlx	Fair Value Adjustment Of Convertible Promissory Notes Related Parties FairValueAdjustmentOfConvertiblePromissoryNotesRelatedParties	-2223000	USD
CY2018Q1	cdlx	Fair Value Adjustment Of Convertible Promissory Notes Related Parties FairValueAdjustmentOfConvertiblePromissoryNotesRelatedParties	0	USD
CY2017Q1	cdlx	Fair Value Assumptions Cost Of Debt Applicable To Convertible Promissory Notes FairValueAssumptionsCostOfDebtApplicableToConvertiblePromissoryNotes	0.10
CY2017Q1	cdlx	Fair Value Assumptions Cost Of Equity Applicable To Convertible Promissory Notes FairValueAssumptionsCostOfEquityApplicableToConvertiblePromissoryNotes	0.22
CY2017Q1	cdlx	Fair Value Assumptions Weighted Average Cost Of Capital FairValueAssumptionsWeightedAverageCostOfCapital	0.23
CY2018Q1	cdlx	Financial Institution Partners Unearned Amounts Not Yet Paid FinancialInstitutionPartnersUnearnedAmountsNotYetPaid	9000000	USD
CY2017Q1	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	16677000	USD
CY2018Q1	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	21420000	USD
CY2017Q1	cdlx	Financial Institution Share And Other Third Party Costs Excluding Noncash Equity Expenseand Deferred Implementation Costs FinancialInstitutionShareAndOtherThirdPartyCostsExcludingNoncashEquityExpenseandDeferredImplementationCosts	16286000	USD
CY2018Q1	cdlx	Financial Institution Share And Other Third Party Costs Excluding Noncash Equity Expenseand Deferred Implementation Costs FinancialInstitutionShareAndOtherThirdPartyCostsExcludingNoncashEquityExpenseandDeferredImplementationCosts	18489000	USD
CY2017Q1	cdlx	Financial Institution Share Expense FinancialInstitutionShareExpense	1500000	USD
CY2017Q4	cdlx	Financial Institution Share Liability Current FinancialInstitutionShareLiabilityCurrent	23914000	USD
CY2018Q1	cdlx	Financial Institution Share Liability Current FinancialInstitutionShareLiabilityCurrent	21376000	USD
CY2018Q1	cdlx	Financial Institutions Agreement Notice Period FinancialInstitutionsAgreementNoticePeriod	P90D
CY2017Q1	cdlx	Increase Decrease In Consumer Incentive Liability IncreaseDecreaseInConsumerIncentiveLiability	-991000	USD
CY2018Q1	cdlx	Increase Decrease In Consumer Incentive Liability IncreaseDecreaseInConsumerIncentiveLiability	-293000	USD
CY2017Q1	cdlx	Increase Decrease In Deferred Financial Institution Implementation Costs IncreaseDecreaseInDeferredFinancialInstitutionImplementationCosts	962000	USD
CY2018Q1	cdlx	Increase Decrease In Deferred Financial Institution Implementation Costs IncreaseDecreaseInDeferredFinancialInstitutionImplementationCosts	1094000	USD
CY2017Q1	cdlx	Increase Decrease In Financial Institution Share Liability IncreaseDecreaseInFinancialInstitutionShareLiability	-4643000	USD
CY2018Q1	cdlx	Increase Decrease In Financial Institution Share Liability IncreaseDecreaseInFinancialInstitutionShareLiability	-2538000	USD
CY2018Q1	cdlx	Long Term Debt And Capital Lease Obligations Including Current Maturities Net Of Debt Issuance Costs And Debt Discount LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturitiesNetOfDebtIssuanceCostsAndDebtDiscount	58551000	USD
CY2017Q1	cdlx	Non Cash Equity Expense Financial Institution Share NonCashEquityExpenseFinancialInstitutionShare	0	USD
CY2018Q1	cdlx	Non Cash Equity Expense Financial Institution Share NonCashEquityExpenseFinancialInstitutionShare	2519000	USD
CY2018Q1	cdlx	Proceeds From Issuance Of Common Stock Trigger Amount For Conversion Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfCommonStockTriggerAmountForConversionOfRedeemableConvertiblePreferredStock	70000000.0	USD
CY2018Q1	cdlx	Proceedsfrom Issuance Initial Public Offering Gross ProceedsfromIssuanceInitialPublicOfferingGross	5500000	USD
CY2018Q1	cdlx	Proceedsfrom Issuance Initial Public Offering Gross ProceedsfromIssuanceInitialPublicOfferingGross	75700000	USD
CY2017Q1	cdlx	Property And Equipment Incurred But Not Yet Paid PropertyAndEquipmentIncurredButNotYetPaid	15000	USD
CY2018Q1	cdlx	Property And Equipment Incurred But Not Yet Paid PropertyAndEquipmentIncurredButNotYetPaid	1155000	USD
CY2017Q1	cdlx	Recoveries Through Financial Institution Share Net RecoveriesThroughFinancialInstitutionShareNet	963000	USD
CY2018Q1	cdlx	Recoveries Through Financial Institution Share Net RecoveriesThroughFinancialInstitutionShareNet	1344000	USD
CY2018Q1	cdlx	Sale Of Stock Issuance Costs SaleOfStockIssuanceCosts	4300000	USD
CY2017Q1	cdlx	Sale Of Stock Issuance Costs SaleOfStockIssuanceCosts	0	USD
CY2018Q1	cdlx	Sale Of Stock Issuance Costs SaleOfStockIssuanceCosts	4279000	USD
CY2018Q1	cdlx	Saleof Stock Discountsand Commissions SaleofStockDiscountsandCommissions	5300000	USD
CY2018Q1	cdlx	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Shares Authorized Annual Percentage Increase SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofSharesAuthorizedAnnualPercentageIncrease	0.05
CY2018Q1	cdlx	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Shares Remaining For Available For Issuance SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofSharesRemainingForAvailableForIssuance	61247	shares
CY2017Q1	cdlx	Sharebased Compensation Capitalized For Software Development SharebasedCompensationCapitalizedForSoftwareDevelopment	0	USD
CY2018Q1	cdlx	Sharebased Compensation Capitalized For Software Development SharebasedCompensationCapitalizedForSoftwareDevelopment	6000	USD
CY2017Q4	cdlx	Warrantsand Rights Outstanding Current WarrantsandRightsOutstandingCurrent	0	USD
CY2018Q1	cdlx	Warrantsand Rights Outstanding Current WarrantsandRightsOutstandingCurrent	17666000	USD
CY2018Q1	dei	Amendment Flag AmendmentFlag	false
CY2018Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2018Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018Q1	dei	Document Period End Date DocumentPeriodEndDate	2018-03-31
CY2018Q1	dei	Document Type DocumentType	10-Q
CY2018Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001666071
CY2018Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20264127	shares
CY2018Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2018Q1	dei	Entity Registrant Name EntityRegistrantName	Cardlytics, Inc.
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1554000	USD
CY2018Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1783000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	48348000	USD
CY2018Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	39907000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4615000	USD
CY2018Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3918000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1066000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	558000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	58693000	USD
CY2018Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	328493000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2906000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2519000	USD
CY2017Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	6639000	USD
CY2018Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	19965000	USD
CY2017Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2900000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	983000	USD
CY2017Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2307000	USD
CY2018Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1500000	USD
CY2017Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	148000	USD
CY2018Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	140000	USD
CY2017Q4	us-gaap	Assets Assets	100758000	USD
CY2018Q1	us-gaap	Assets Assets	157807000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	74629000	USD
CY2018Q1	us-gaap	Assets Current AssetsCurrent	136098000	USD
CY2017Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	44000	USD
CY2018Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	23000	USD
CY2017Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	57000	USD
CY2018Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	52000	USD
CY2018Q1	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	75000	USD
CY2018Q1	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	13000	USD
CY2018Q1	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	24000	USD
CY2018Q1	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	20000	USD
CY2018Q1	us-gaap	Capital Leases Future Minimum Payments Remainder Of Fiscal Year CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear	18000	USD
CY2017Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	433000	USD
CY2018Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	880000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22838000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24353000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21262000	USD
CY2017Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	2645000	shares
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	89785000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22968000	USD
CY2017Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24353000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21262000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	89785000	USD
CY2017Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1385000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	68523000	USD
CY2017Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	27.68
CY2013Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	23.64
CY2016Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	20.00
CY2017Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	17500	shares
CY2016Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	97125	shares
CY2017Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	110000	shares
CY2018Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2013Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	644365	shares
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83000000	shares
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83000000	shares
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3439000	shares
CY2018Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20226000	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3439000	shares
CY2018Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20226000	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2018Q1	us-gaap	Common Stock Value CommonStockValue	7000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12583000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20563000	USD
CY2017Q2	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	801329	shares
CY2017Q1	us-gaap	Costs And Expenses CostsAndExpenses	33929000	USD
CY2018Q1	us-gaap	Costs And Expenses CostsAndExpenses	42530000	USD
CY2018Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	59365000	USD
CY2018Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	615000	USD
CY2016Q4	us-gaap	Deferred Costs DeferredCosts	0	USD
CY2017Q1	us-gaap	Deferred Costs DeferredCosts	776000	USD
CY2017Q4	us-gaap	Deferred Costs DeferredCosts	3144000	USD
CY2018Q1	us-gaap	Deferred Costs DeferredCosts	0	USD
CY2018Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	274000	USD
CY2017Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	3670000	USD
CY2018Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	3554000	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	132000	USD
CY2018Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	189000	USD
CY2016Q4	us-gaap	Deferred Set Up Costs Noncurrent DeferredSetUpCostsNoncurrent	8451000	USD
CY2017Q1	us-gaap	Deferred Set Up Costs Noncurrent DeferredSetUpCostsNoncurrent	7097000	USD
CY2017Q4	us-gaap	Deferred Set Up Costs Noncurrent DeferredSetUpCostsNoncurrent	13625000	USD
CY2018Q1	us-gaap	Deferred Set Up Costs Noncurrent DeferredSetUpCostsNoncurrent	12119000	USD
CY2017Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	765000	USD
CY2018Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	910000	USD
CY2017Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	765000	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	910000	USD
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-4.80
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.54
CY2017Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46000	USD
CY2018Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	175000	USD
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4638000	USD
CY2018Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3263000	USD
CY2018Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	10400000	USD
CY2017Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	327000	USD
CY2018Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	9172000	USD
CY2013Q2	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0
CY2013Q2	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P5Y3M18D
CY2013Q2	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.50
CY2017Q1	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.53
CY2013Q2	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.020
CY2013Q2	us-gaap	Fair Value Inputs Offered Quotes FairValueInputsOfferedQuotes	13.00
CY2017Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4689000	USD
CY2018Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6582000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12463000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20055000	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	631000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-408000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6672000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8623000	USD
CY2017Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2802000	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1836000	USD
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	551000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1520000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	528000	USD
CY2018Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	359000	USD
CY2017Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2644000	USD
CY2018Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1749000	USD
CY2017Q1	us-gaap	Interest Paid InterestPaid	188000	USD
CY2018Q1	us-gaap	Interest Paid InterestPaid	247000	USD
CY2017Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	6200000	USD
CY2018Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	7600000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	100758000	USD
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	157807000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	42139000	USD
CY2018Q1	us-gaap	Liabilities Current LiabilitiesCurrent	80801000	USD
CY2017Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	70868000	USD
CY2018Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	36448000	USD
CY2017Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2018Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	25634000	USD
CY2018Q1	us-gaap	Long Term Debt LongTermDebt	58476000	USD
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	57012000	USD
CY2018Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	58551000	USD
CY2018Q1	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	59440000	USD
CY2018Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour	13000	USD
CY2018Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree	24000	USD
CY2018Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo	59385000	USD
CY2018Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	18000	USD
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	44000	USD
CY2018Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	25657000	USD
CY2018Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2018Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2018Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	59365000	USD
CY2018Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	56968000	USD
CY2018Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	32894000	USD
CY2017Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	25081000	USD
CY2018Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	USD
CY2017Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	31830000	USD
CY2018Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	32842000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7565000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	69232000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-402000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-794000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5824000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-90000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-12463000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-20055000	USD
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12707000	USD
CY2018Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20212000	USD
CY2017Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5415000	USD
CY2018Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10238000	USD
CY2018Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7048000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-9817000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4224000	USD
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	988000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-120000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-508000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-508000	USD
CY2017Q1	us-gaap	Other Noncash Expense OtherNoncashExpense	229000	USD
CY2018Q1	us-gaap	Other Noncash Expense OtherNoncashExpense	2253000	USD
CY2017Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	162000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	683000	USD
CY2017Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2898000	USD
CY2018Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2748000	USD
CY2017Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	181000	USD
CY2018Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1232000	USD
CY2017Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	16000	USD
CY2018Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2000	USD
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	386000	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	418000	USD
CY2017Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	0	USD
CY2018Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	374000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2121000	USD
CY2018Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3658000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	66100000	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	270000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	70490000	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	7500000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7319000	USD
CY2018Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7363000	USD
CY2017Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-4000	USD
CY2018Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-32000	USD
CY2017Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	24000	USD
CY2018Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	26000	USD
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3013000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3459000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	130000	USD
CY2017Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2018Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-268445000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-288500000	USD
CY2017Q1	us-gaap	Revenues Revenues	26881000	USD
CY2018Q1	us-gaap	Revenues Revenues	32713000	USD
CY2018Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	421355	shares
CY2018Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	5821355	shares
CY2017Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7232000	USD
CY2018Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	8216000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	983000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2900000	USD
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	6000	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1875000	shares
CY2017Q2	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	300000	USD
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	35000	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	9000	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	103000	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	124000	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	29000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.91
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.32
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.00
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2137000	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2170000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2514000	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2379000	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	15.00
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	15.20
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	18.42
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	18.37
CY2017Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.57
CY2018Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.22
CY2017Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	14.21
CY2018Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	15.88
CY2017Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	20.59
CY2018Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	25.65
CY2017Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	11.81
CY2018Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	24.24
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2017Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	600000	USD
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1200000	USD
CY2017Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	76000	shares
CY2018Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	26000	shares
CY2018Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	196594000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	66101000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	108000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-208686000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	40558000	USD
CY2018Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.25
CY2017Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	244000	USD
CY2018Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	157000	USD
CY2017Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	196437000	USD
CY2018Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2018Q1	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2017Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	82683212	shares
CY2017Q2	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	96131002	shares
CY2018Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	25000000	shares
CY2017Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	10230000	USD
CY2018Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	USD
CY2016Q3	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	1000000	USD
CY2018Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	13093000	shares
CY2018Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Significant items subject to such estimates and assumptions include revenue recognition, internal-use software development costs, income taxes, stock-based compensation, derivative instruments, income tax valuation allowance, contingencies and changes in fair value of our convertible promissory notes. We base our estimates on historical experience and also on assumptions that we believe are reasonable. Changes in facts or circumstances may cause us to change our assumptions and estimates in future periods and it is possible that actual results could differ from our current or revised future estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-18-006582-index-headers.html	Edgar Link	pending
0001628280-18-006582-index.html	Edgar Link	pending
0001628280-18-006582.txt	Edgar Link	pending
0001628280-18-006582-xbrl.zip	Edgar Link	pending
cardlytics_logoa02.jpg	Edgar Link	pending
cdlx-20180331.xml	Edgar Link	completed
cdlx-20180331.xsd	Edgar Link	pending
cdlx-20180331_cal.xml	Edgar Link	unprocessable
cdlx-20180331_def.xml	Edgar Link	unprocessable
cdlx-20180331_lab.xml	Edgar Link	unprocessable
cdlx-20180331_pre.xml	Edgar Link	unprocessable
cdlx_form10-qx2018q1.htm	Edgar Link	pending
cdlx_form10-qx2018q1xex311.htm	Edgar Link	pending
cdlx_form10-qx2018q1xex312.htm	Edgar Link	pending
cdlx_form10-qx2018q1xex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CDLX
Cardlytics, Inc. Stock $cdlx

2018 Q1 Form 10-Q Financial Statement

#000162828018006582 Filed on May 10, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDLX Cardlytics, Inc. Stock $cdlx

2018 Q1 Form 10-Q Financial Statement

#000162828018006582 Filed on May 10, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDLX
Cardlytics, Inc. Stock $cdlx